Chicago-based Amphix Bio (NSF-2151711) uses supramolecular chemistry to activate regenerative signals and spur tissue growth. Their work focuses on devices and therapies for bone, neural, and cartilage regeneration. The company recently received breakthrough device designation from the FDA for a material used in spinal surgeries that induces bone growth. Article via Medical Device Network